Sébastien Benzekry
Sébastien Benzekry
Scientific Researcher, Inria
Adresse e-mail validée de inria.fr - Page d'accueil
Titre
Citée par
Citée par
Année
Classical mathematical models for description and prediction of experimental tumor growth
S Benzekry, C Lamont, A Beheshti, A Tracz, JML Ebos, L Hlatky, ...
PLoS Comput Biol 10 (8), e1003800, 2014
3462014
Mathematical modeling of cancer immunotherapy and its synergy with radiotherapy
R Serre, S Benzekry, L Padovani, C Meille, N André, J Ciccolini, F Barlesi, ...
Cancer research 76 (17), 4931-4940, 2016
912016
Modeling spontaneous metastasis following surgery: an in vivo-in silico approach
S Benzekry, A Tracz, M Mastri, R Corbelli, D Barbolosi, JML Ebos
Cancer research 76 (3), 535-547, 2016
622016
Metronomic reloaded: Theoretical models bringing chemotherapy into the era of precision medicine
S Benzekry, E Pasquier, D Barbolosi, B Lacarelle, F Barlési, N André, ...
Seminars in Cancer Biology 35, 53-61, 2015
582015
Maximum tolerated dose versus metronomic scheduling in the treatment of metastatic cancers
S Benzekry, P Hahnfeldt
Journal of theoretical biology 335, 235-244, 2013
402013
Global dormancy of metastases due to systemic inhibition of angiogenesis
S Benzekry, A Gandolfi, P Hahnfeldt
PloS one 9 (1), e84249, 2014
392014
A new mathematical model for optimizing the combination between antiangiogenic and cytotoxic drugs in oncology
S Benzekry, G Chapuisat, J Ciccolini, A Erlinger, F Hubert
Comptes Rendus Mathematique 350 (1-2), 23-28, 2012
382012
Modeling the impact of anticancer agents on metastatic spreading
S Benzekry, N André, A Benabdallah, J Ciccolini, C Faivre, F Hubert, ...
Mathematical Modelling of Natural Phenomena 7 (1), 306-336, 2012
362012
Computational modelling of metastasis development in renal cell carcinoma
E Baratchart, S Benzekry, A Bikfalvi, T Colin, LS Cooley, R Pineau, ...
PLoS computational biology 11 (11), e1004626, 2015
332015
Mathematical modeling of tumor–tumor distant interactions supports a systemic control of tumor growth
S Benzekry, C Lamont, D Barbolosi, L Hlatky, P Hahnfeldt
Cancer research 77 (18), 5183-5193, 2017
292017
Host age is a systemic regulator of gene expression impacting cancer progression
A Beheshti, S Benzekry, JT McDonald, L Ma, M Peluso, P Hahnfeldt, ...
Cancer research 75 (6), 1134-1143, 2015
282015
Mathematical analysis of a two-dimensional population model of metastatic growth including angiogenesis
B Sébastien
Journal of Evolution Equations 11 (1), 187-213, 2011
272011
Model driven optimization of antiangiogenics+ cytotoxics combination: application to breast cancer mice treated with bevacizumab+ paclitaxel doublet leads to reduced tumor …
S Mollard, J Ciccolini, DC Imbs, R El Cheikh, D Barbolosi, S Benzekry
Oncotarget 8 (14), 23087, 2017
262017
Mathematical and numerical analysis of a model for anti-angiogenic therapy in metastatic cancers
S Benzekry
ESAIM: Mathematical Modelling and Numerical Analysis-Modélisation …, 2012
262012
Theoretical investigation of the efficacy of antiangiogenic drugs combined to chemotherapy in xenografted mice
F Lignet, S Benzekry, S Wilson, F Billy, O Saut, M Tod, B You, AA Berkane, ...
Journal of theoretical biology 320, 86-99, 2013
252013
Design principles for cancer therapy guided by changes in complexity of protein-protein interaction networks
S Benzekry, JA Tuszynski, EA Rietman, GL Klement
Biology direct 10 (1), 1-14, 2015
202015
Pharmacokinetics variability: Why nanoparticles are not just magic-bullets in oncology
A Rodallec, S Benzekry, B Lacarelle, J Ciccolini, R Fanciullino
Critical Reviews in Oncology/Hematology 129, 1-12, 2018
192018
Turning cold tumors into hot tumors: harnessing the potential of tumor immunity using nanoparticles
A Rodallec, G Sicard, R Fanciullino, S Benzekry, B Lacarelle, G Milano, ...
Expert opinion on drug metabolism & toxicology 14 (11), 1139-1147, 2018
172018
Revisiting bevacizumab+ cytotoxics scheduling using mathematical modeling: proof of concept study in experimental non‐small cell lung carcinoma
DC Imbs, R El Cheikh, A Boyer, J Ciccolini, C Mascaux, B Lacarelle, ...
CPT: pharmacometrics & systems pharmacology 7 (1), 42-50, 2018
152018
In vivo bioluminescence tomography for monitoring breast tumor growth and metastatic spreading: comparative study and mathematical modeling
S Mollard, R Fanciullino, S Giacometti, C Serdjebi, S Benzekry, J Ciccolini
Scientific reports 6 (1), 1-10, 2016
152016
Le système ne peut pas réaliser cette opération maintenant. Veuillez réessayer plus tard.
Articles 1–20